Anticancer Activity of Bitter Melon-Derived Vesicles Extract against Breast Cancer
Open Access
Abstract
Due to their low immunogenicity, high biocompatibility and ready availability in large quantities, plant-derived vesicles extracts have attracted considerable interest as a novel nanomaterial in tumor therapy. Bitter melon, a medicinal and edible plant, has been reported to exhibit excellent antitumor effects. It is well-documented that breast cancer gravely endangers women’s health, and more effective therapeutic agents must be urgently explored. Therefore, we investigated whether bitter melon-derived vesicles extract (BMVE) has antitumor activity against breast cancer. Ultracentrifugation was used to isolate BMVE with a typical “cup-shaped” structure and an average size of approximately 147 nm from bitter melon juice. The experimental outcomes indicate that 4T1 breast cancer cells could efficiently internalize BMVE, which shows apparent anti-proliferative and migration-inhibiting effects. In addition, BMVE also possesses apoptosis-inducing effects on breast cancer cells, which were achieved by stimulating the production of reactive oxygen species (ROS) and disrupting mitochondrial function. Furthermore, BMVE could dramatically inhibit tumor growth in vivo with negligible adverse effects. In conclusion, BMVE exhibits a pronounced antitumor effect on 4T1 breast cancer cells, which has great potential for use in tumor therapy.Keywords
Funding Information
- National Natural Science Foundation of China (82073380, 81803094)
- National Natural Science Foundation of China (82073380, 81803094)
This publication has 31 references indexed in Scilit:
- Bitter Melon Enhances Natural Killer–Mediated Toxicity against Head and Neck Cancer CellsCancer Prevention Research, 2017
- Extracellular Vesicles: Unique Intercellular Delivery VehiclesTrends in Cell Biology, 2017
- Edible Ginger-derived Nano-lipids Loaded with Doxorubicin as a Novel Drug-delivery Approach for Colon Cancer TherapyMolecular Therapy, 2016
- Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancerBiomaterials, 2016
- Bitter melon: a panacea for inflammation and cancerChinese Journal of Natural Medicines, 2016
- Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneityAdvanced Drug Delivery Reviews, 2015
- Bitter Melon Reduces Head and Neck Squamous Cell Carcinoma Growth by Targeting c-Met SignalingPLOS ONE, 2013
- Delivery of therapeutic agents by nanoparticles made of grapefruit-derived lipidsNature Communications, 2013
- Signal integration by JNK and p38 MAPK pathways in cancer developmentNature Reviews Cancer, 2009
- Rapid Generation of Single-Tumor Spheroids for High-Throughput Cell Function and Toxicity AnalysisSLAS Discovery, 2006